Enanta Pharmaceuticals reported $1.51M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbvie ABBV:US $ 63522M 667M
Acorda Therapeutics ACOR:US $ 182.44M 3.77M
Amgen AMGN:US $ 36010M 2788M
Anika Therapeutics ANIK:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
AstraZeneca AZN:LN 28805M 83M
Biocryst Pharmaceuticals BCRX:US $ 604.46M 19M
Biogen BIIB:US $ 6275.7M 1.7M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Clovis Oncology CLVS:US $ 614M 7.27M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Gilead Sciences GILD:US $ 25183M 4M
GlaxoSmithKline GSK:LN 29226M 8654M
Halozyme Therapeutics HALO:US $ 788.1M 0.84M
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Insmed INSM:US $ 806.66M 225.97M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
IONIS PHARMACEUT IONS:US $ 1247.93M 19.91M
Johnson & Johnson JNJ:US $ 28851M 1134M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Ligand Pharmaceuticals LGND:US $ 176.54M 144.18M
Marinus Pharmaceuticals MRNS:US $ 69.93M 29.12M
Merk MRK:US $ 30586M 104M
Neurocrine Biosciences NBIX:US $ 377.7M 42.6M
Novartis NOVN:VX SF 24373M 150M
Novavax NVAX:US $ 0M 323.46M
Pfizer PFE:US $ 35656M 539M
Ptc Therapeutics PTCT:US $ 975.65M 0.99M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
Vital Therapies VTL:US $ 0M 0M
YTE INCY:US $ 31.38M 0.25M